Construction of a novel gene therapy lentiviral vector for drug resistant selection and detection in vivo / 生物工程学报
Chinese Journal of Biotechnology
;
(12): 256-261, 2008.
Artículo
en Chino
| WPRIM
| ID: wpr-276130
ABSTRACT
Lentiviral vectors were powerful gene delivery tools for gene therapy. We developed a new lentiviral vector pBobi-MIL that constitutively expressed O6-methylguanine-DNAmethyltransferase (MGMT) and Luciferase, linked by the internal ribosomal entry site (IRES), to realize drug tolerance and real time monitoring in vivo. All results from RT-PCR, drug treating clones forming, immunofluorometric assay and chemiluminescence detection showed that cells infected by recombinant lentivirus L-MIL simultaneously expressed these two genes. This lays the foundation for the further research in gene therapy and can also help identify lentivirus titer.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Resistencia a Medicamentos
/
Metilasas de Modificación del ADN
/
Terapia Genética
/
Lentivirus
/
Proteínas Supresoras de Tumor
/
Enzimas Reparadoras del ADN
/
Vectores Genéticos
/
Genética
/
Luciferasas
/
Metabolismo
Tipo de estudio:
Estudio diagnóstico
Límite:
Humanos
Idioma:
Chino
Revista:
Chinese Journal of Biotechnology
Año:
2008
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS